CRYOTHERAPY CENTER BUSINESS PLAN

I. Executive Summary

Company Description

The company, operating as CryoWell Clinic (name chosen for clarity and brand positioning), launches in Q1 2026 as a premier wellness center in a high-traffic U.S. metropolitan area. We operate in the health and wellness sector, specializing in advanced cryotherapy: whole-body cryo-chambers and localized cold therapy systems. Core services combine fast-turn, spa-quality cryotherapy sessions with high-margin ancillary offerings—compression therapy, infrared sauna, and targeted recovery protocols—backed by cutting-edge equipment and licensed technicians. One-liner: We sell recurring recovery through membership plans and premium add-ons.

We deliver services via appointment and walk-in flow designed for high throughput, scaling from 20 to 115 visits per day over five years. Our target customers are competitive athletes, performance-driven professionals, and people with chronic pain seeking non-pharmacologic relief. Short-term goals: achieve 40 daily visits and 600 memberships by month 12. Long-term goals: reach 115 daily visits, 4,200 memberships, and expand to two additional metro sites by year 5. Primary differentiator: membership-first economics, clinical-grade equipment, and a streamlined, repeatable service model focused on retention and high lifetime value. One-liner: We convert frequent users into predictable, recurring revenue.

Problem

Active individuals, professional athletes, and people with chronic inflammatory conditions face prolonged muscle recovery times and persistent physical fatigue, which reduce training quality, daily performance, and return-to-work timelines. Elite-level recovery technologies and protocols remain largely unavailable to the general public, creating a widening care gap between those who can access advanced treatment and those who cannot.

Current options rely heavily on pharmaceuticals, provide limited non-drug relief, or are inaccessible; there is a clear need for fast, effective, scientifically backed, and widely available treatments that lower inflammation and accelerate natural healing.

Solution

The center addresses slow recovery, persistent inflammation, and limited access to professional-grade cryotherapy by providing three-minute whole-body cryotherapy and targeted localized sessions completed in under 15 minutes inside a spa-like facility. This delivers systemic recovery for athletes and quick, focused relief for busy professionals, offering personalized consultations and advanced monitoring to replace time-consuming or pharmaceutical-heavy alternatives.

One line: Fast, professional cryotherapy that fits a lunch break and scales from everyday athletes to chronic-condition clients.

Mission Statement

Our mission is to empower people to recover faster, live pain-free, and optimize physical performance using the most advanced cryotherapy technology and protocols. We commit to a safe, personalized, and invigorating recovery experience that serves athletes and health-conscious professionals with measurable results. Through continuous innovation, professional care, and outstanding service, we aim to become the premier recovery destination in the United States.

Key Success Factors

Critical operational and commercial elements required to achieve the plan's targets.

• Grow visits from 20 to 115 daily through aggressive marketing.
• Convert memberships to reach 50% recurring revenue by 2030.
• Control liquid nitrogen supply and labor costs tightly.
• Hit a 34-month payback via disciplined capital allocation.
• Deliver consistent service quality to achieve 3.3 ROE.

Financial Summary

The financial summary shows a path to operational breakeven in Jan-27 and to positive EBITDA growth by year three.

Financial requirements: total capital expenditure for 2026 launch is $316,500 and minimum cash required is $537,000; anticipated return: IRR 5.0% with a 34-month payback to initial investors.

Overall outlook: profitable growth to $1.553M EBITDA by year five and positive cash flow after Jan-27.

Funding Requirements

To fund the 2026 launch the project requires capital to cover $316,500 in capex, $648,000 in working capital (including a $111,000 year‑one EBITDA shortfall and a $537,000 minimum cash reserve), for a total estimated funding need of approximately $850,000; the plan targets break-even in January 2027 and $1,553,000 annual EBITDA by year five.